These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 13505137)

  • 1. [Preliminary notes on the behavior of several tests of serum eucolloidality in patients of heart failure].
    LUCENTINI L; DE SIMONE M
    Policlinico Med; 1957; 64(5):374-86. PubMed ID: 13505137
    [No Abstract]   [Full Text] [Related]  

  • 2. A range of circulatory and renal responses to rapidly induced in creases in serum colloid osmotic pressure in edematous states of varied etiology.
    ARMSTRONG SH; GRISSOM R; PASCALE LR; DUBIN A; BECKER RJ; GRIFFIN JA; HELWIG FC
    Trans Am Clin Climatol Assoc; 1956-1957; 68():174-90; discussion 191-2. PubMed ID: 13486618
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of Di Maria's reaction, blood protein picture and several serum lability tests in various liver diseases].
    GIAMBRONE I; CACOPARDO A; DEODATA M; CANNADA E
    Riforma Med; 1958 Nov; 72(47):1328-32. PubMed ID: 13624520
    [No Abstract]   [Full Text] [Related]  

  • 4. Difference of baseline serum copper levels between groups of patients with different one year mortality and morbidity and chronic heart failure.
    Málek F; Dvorák J; Jiresová E; Spacek R
    Cent Eur J Public Health; 2003 Dec; 11(4):198-201. PubMed ID: 14768782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure.
    Arimoto T; Takeishi Y; Niizeki T; Takabatake N; Okuyama H; Fukui A; Tachibana H; Nozaki N; Hirono O; Tsunoda Y; Miyashita T; Shishido T; Takahashi H; Koyama Y; Kubota I
    J Card Fail; 2005 Oct; 11(8):595-601. PubMed ID: 16230262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center.
    Amir O; Paz H; Ammar R; Yaniv N; Schliamser JE; Lewis BS
    Isr Med Assoc J; 2008 Feb; 10(2):109-12. PubMed ID: 18432021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial.
    Rossi J; Bayram M; Udelson JE; Lloyd-Jones D; Adams KF; Oconnor CM; Stough WG; Ouyang J; Shin DD; Orlandi C; Gheorghiade M
    Acute Card Care; 2007; 9(2):82-6. PubMed ID: 17573581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure.
    Iwaoka M; Obata JE; Abe M; Nakamura T; Kitta Y; Kodama Y; Kawabata K; Takano H; Fujioka D; Saito Y; Kobayashi T; Hasebe H; Kugiyama K
    J Card Fail; 2007 May; 13(4):247-53. PubMed ID: 17517342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress.
    Yamaji M; Tsutamoto T; Kawahara C; Nishiyama K; Yamamoto T; Fujii M; Horie M
    Circ Heart Fail; 2009 Nov; 2(6):608-15. PubMed ID: 19919986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum copper as a marker of inflammation in prediction of short term outcome in high risk patients with chronic heart failure.
    Malek F; Jiresova E; Dohnalova A; Koprivova H; Spacek R
    Int J Cardiol; 2006 Nov; 113(2):e51-3. PubMed ID: 16843542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characterization of atypical colloids in plasmocytoma serum].
    POSPISIL M; WIEDERMANN D
    Cas Lek Cesk; 1957 Nov; 96(46):1441-3. PubMed ID: 13500353
    [No Abstract]   [Full Text] [Related]  

  • 12. Serial monitoring of brain natriuretic peptide concentrations for drug therapy management in patients with chronic heart failure.
    Gallegos PJ; Maclaughlin EJ; Haase KK
    Pharmacotherapy; 2008 Mar; 28(3):343-55. PubMed ID: 18294114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry.
    Assmus B; Fischer-Rasokat U; Honold J; Seeger FH; Fichtlscherer S; Tonn T; Seifried E; Schächinger V; Dimmeler S; Zeiher AM;
    Circ Res; 2007 Apr; 100(8):1234-41. PubMed ID: 17379833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical differences between heart failure versus ischemic patients].
    Pinelli M; Bindi M; Moroni F; Rosada J; Castiglioni M
    Recenti Prog Med; 2007; 98(7-8):378-83. PubMed ID: 17685185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: A hospital cohort study.
    Haugen E; Furukawa Y; Isic A; Fu M
    Int J Cardiol; 2008 Apr; 125(2):216-9. PubMed ID: 18234365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure.
    Akhter MW; Aronson D; Bitar F; Khan S; Singh H; Singh RP; Burger AJ; Elkayam U
    Am J Cardiol; 2004 Oct; 94(7):957-60. PubMed ID: 15464689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
    Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
    Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inflammatory markers in heart failure].
    Ozmen N; Cebeci BS; Kardeşoğlu E
    Anadolu Kardiyol Derg; 2006 Mar; 6(1):51-4. PubMed ID: 16524802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences with serum BNP (B type natriuretic peptide) in patients with systolic and diastolic heart failure].
    Lukács I; Fey E; Kárpáti P
    Orv Hetil; 2005 Sep; 146(37):1919-23. PubMed ID: 16255376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic and prognostic value of B-type natriuretic peptides in heart failure or signs of heart failure].
    Souverijn JH
    Ned Tijdschr Geneeskd; 2008 Jan; 152(4):231; author reply 231. PubMed ID: 18320951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.